Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical D
Murepavadin (POL7080), Polyphor‘s lead investigational antibiotic targeting Gram-negative bacteria, behaved as expected and was...
EffRx Pharmaceuticals Signs Exclusive License Agreement with Pharmaxis for the Registration and Comm
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today...
Slammed by Side Effects: The Downside of Antibiotics
Everyone with cystic fibrosis knows that feeling. Sometimes, it creeps up on you slowly. Other times, it hits right away, like a truck...
New study confirms vaping is not safer than smoking- it obstructs mucus clearance
Research published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine confirms that...
Trial of Nebulized CF Candidate Therapy Completes Single-ascending Dosing
The RESTORE-CF clinical trial investigating Translate Bio’s candidate therapy MRT5005 has completed the single-ascending dose regimen in...
Specific Peptide May Lower Antibiotic Resistance of P. aeruginosa Bacteria, Study Reports
Expression of a peptide called RpoN* in antibiotic-resistant Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients made the...
Life-saving designer ‘NINJA virus’ hailed as medical breakthrough in curing infection
A VIRUS cocktail designed to seek and destroy bacteria has cleared a 15-year-old lung transplant patient of an antibiotic-resistant...
Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month
May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and has been using gene therapy...
Phages, Viruses that Attack Bacteria, Are a Potential Therapy Against Infections, Case Report Sugges
The case report of a cystic fibrosis (CF) patient suggests that phages — viruses that naturally infect and kill bacteria — are a...
SNSP113 (Previously SYGN113)
SNSP113 is an inhaled therapy being developed by Synspira Therapeutics that aims to ease pulmonary infections, airway congestion, and...
